LicianPro

Day One Biopharmaceuticals Inc

DAWN

  • Mkt cap

    $656.83M

  • EV/Sales

    2.91

  • P/E ratio

    —

  • FY2025 Revenue

    $158.18M

  • EPS (9mo ended 2025-09-30)

    −$0.83

  • Gross Margin (FY2025)

    —

  • Profit Margin (FY2025)

    −67.85%

  • Beta

    −1.30

  • Div yield

    —

  • Sector

    Healthcare

DAWN at a glance

DAWN AI brief

AI

Overview

What matters now, from SEC filings and analyst ratings

Takeaway

A takeaway appears here once the latest filing has been analyzed.

Analysts

Quant grade metrics

Sector-relative grades for valuation, growth, profitability, momentum and revisions

How it works

Financials

Earnings

Ownership

Insiders

Form 4 trades, last 90 days

All trades

No open-market insider buy or sell of DAWN since Aug 20, 2026.

Filings

Latest SEC filings

All filings

Source: SEC EDGAR · Latest filing Jan 12, 2026

News

Latest stored headlines

All news

DAWN — Day One Biopharmaceuticals Inc · rev $158.2M

DAWN Key Statistics

  • Market Cap: $656.8M

Day One Biopharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full DAWN income, balance, and cash tables.

  • Revenue$158.2M
  • Net Income-$107.3M
  • Total Assets$507.8M
  • Free Cash Flow-$104.1M

DAWN recent filings

DAWN FAQ

What industry is DAWN in?

Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company in the Healthcare sector.

What are DAWN's latest revenue and net income?

Latest cached Day One Biopharmaceuticals Inc (DAWN) revenue for Dec 31, 2025 was $158.2M. Net income was -$107.3M. Statements: https://lician.com/financials/dawn

What is DAWN's market cap?

Day One Biopharmaceuticals Inc (DAWN) market capitalization is $656.8M on the latest cached snapshot.

What is the latest DAWN SEC filing?

The latest cached DAWN filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/dawn

DAWN chart and investment calculator load when you scroll here.